•
Mar 31, 2021

Molina Q1 2021 Earnings Report

Molina Healthcare's financial performance for Q1 2021 reflected substantial revenue growth and improved profitability.

Key Takeaways

Molina Healthcare reported a strong first quarter in 2021, with a 33% increase in GAAP earnings per diluted share, reaching $3.89, and a 47% increase in adjusted earnings per diluted share, amounting to $4.44. The company served approximately 4.6 million members, marking a 35% increase compared to the previous year, and premium revenue rose by 47% to $6.3 billion. Due to the strong performance, Molina increased its full year 2021 premium revenue and adjusted earnings guidance.

GAAP net income increased by 33% to $3.89 per diluted share compared to Q1 2020.

Adjusted net income rose by 47% to $4.44 per diluted share compared to Q1 2020.

Membership grew by 35%, reaching approximately 4.6 million members.

Premium revenue increased by 47% to $6.3 billion compared to Q1 2020.

Total Revenue
$6.52B
Previous year: $4.55B
+43.4%
EPS
$4.44
Previous year: $3.02
+47.0%
Medicaid Membership
3.86M
Previous year: 2.97M
+29.9%
Medicare Membership
126K
Previous year: 105K
+20.0%
Marketplace Membership
620K
Previous year: 329K
+88.4%
Gross Profit
$861M
Previous year: $615M
+40.0%
Cash and Equivalents
$4.43B
Previous year: $2.37B
+87.4%
Free Cash Flow
$552M
Previous year: $122M
+352.5%
Total Assets
$9.95B
Previous year: $7.13B
+39.6%

Molina

Molina

Molina Revenue by Segment

Forward Guidance

Molina Healthcare increased its full year 2021 premium revenue guidance to more than $24.0 billion and adjusted earnings guidance to no less than $13.00 per diluted share.

Positive Outlook

  • The Public Health Emergency period and associated pause on Medicaid membership redeterminations is now expected to continue through the third quarter of 2021.
  • Strong membership pickup in the Marketplace open enrollment.
  • Slower membership attrition during the quarter.
  • Premium revenue guidance increased to more than $24.0 billion.
  • Adjusted earnings per share guidance increased to no less than $13.00.

Challenges Ahead

  • Company continues to be cautious in forecasting utilization trends in the remaining nine months of the year due to COVID pandemic.
  • COVID-related risk corridors.
  • Direct COVID medical costs.
  • Impacts were varied across lines of business due to COVID.
  • Temporary industry-wide challenge of risk scores that do not fully reflect the acuity of the membership.

Revenue & Expenses

Visualization of income flow from segment revenue to net income